Serum IGF-I and C-reactive protein in healthy black and white young men: The CARDIA male hormone study

https://doi.org/10.1016/j.ghir.2008.12.002Get rights and content

Abstract

Objective

Animal and human studies suggest that C-reactive protein (CRP) may be inversely associated with serum insulin-like growth factor-I (IGF-I) concentrations. However, most human studies have not controlled adequately for confounding factors, particularly nutritional intake. This population-based study examined whether CRP is inversely associated with IGF-I and IGFBP-3 concentrations.

Methods

In cross-sectional analysis, multivariable linear regression with adjustment for age, BMI, smoking status, alcohol intake, and nutritional factors was used to relate log CRP, the independent variable, to IGF-I and IGFBP-3 in a sample of black (n = 364) and white men (n = 486) separately by race.

Results

Only black men had positive findings: log CRP was significantly associated with IGF-I (β = −13.1 ng/ml, p = 0.02) and the difference in mean IGF-I concentrations between the highest and lowest quartiles of CRP was 26 ng/ml. There was a statistically significant interaction between log CRP and smoking status (p = 0.02); the regression coefficient for IGF-I predicted from log CRP was significant in smokers (β = −39.8 ng/ml, p = 0.0001), but not in non-smokers. The difference in mean IGF-I concentrations between highest and lowest quartiles of CRP was 100 ng/ml for black smokers. There were no associations for IGFBP-3.

Conclusions

In our study, CRP levels are inversely associated with IGF-I concentrations in black male smokers; however, the causal nature of the association is unclear and should be studied further.

Introduction

Insulin-like growth factor-I (IGF-I) is a peptide hormone produced primarily by the liver and is regulated, in part, by growth hormone (GH). The predominate binding protein (BP), IGFBP-3, regulates IGF-I’s bioavailability and mediates its actions through the IGFBP-3 receptor [1], [2]. Early in life, the GH-IGF-axis has a critical role in normal postnatal growth. Disruption of this axis with reductions in IGF-I concentrations results in growth impairment. Stunted growth is a complication of childhood diseases characterized by inflammation such as inflammatory bowel disease (IBD) and systemic juvenile idiopathic arthritis [3]. It is hypothesized that one mechanism by which inflammatory diseases in children might lead to stunted growth is through the IGF-axis. That is, inflammatory cytokines, which stimulate C-reactive protein (CRP) production [4], reduce IGF-I concentrations, contributing to stunted growth. This hypothesis is also supported by several animal models [5], [6].

In addition to their significance to postnatal growth, the IGF-axis and inflammatory processes are both important in a number of disease contexts. In adults, serum IGF-I concentrations and markers of inflammation have been associated with risk of cardiovascular disease and the metabolic syndrome [7], [8], [9], [10], [11], type 2 diabetes [12], [13], and site-specific cancers [14], [15], [16], [17], [18], [19]. Most of these studies [7], [10], [12], [13], [14], [15], [16], [17], [18], [19] focused separately either on the IGF-axis or on inflammatory markers but did not consider their inter-relationships. On the other hand, in adult patients with cancer or IBD, inflammatory markers have been inversely correlated, albeit not causally related, with IGF-I levels [20], [21], [22]. However, these studies were limited in that nutritional deficiency concomitant with these diseases may have contributed to reduced IGF-I levels. It is well established that energy and protein restriction reduces IGF-I concentrations [23], [24]. Two population-based studies reported inverse correlations between CRP and IGF-I, but in neither study was it clear that potential confounding factors, such as body mass index (BMI) or smoking, were adjusted for in computing these correlations [9], [25].

Importantly, no large, population-based study in healthy adults has examined the association of IGF-I with inflammatory factors while controlling for diet [26], [27], [28] or other potential confounding factors. Given the independent importance of the IGF-axis and inflammatory processes in health and disease states, it is essential to determine whether the causal relation between inflammation and IGF-I suggested by animal studies [5], [6] can be observed at the population level. The Coronary Artery Risk Development in Young Adults (CARDIA) male hormone study (CMHS) provides a unique opportunity to test the hypothesis that CRP is inversely associated with IGF-I in healthy, well-nourished men. Because of racial differences in cytokine genotype distributions [29], mean serum IGF-I levels [30] and nicotine metabolism [31], and differential impact of cigarette smoking on hepatic drug metabolism [32], it is also necessary to examine the interactions of race and smoking with CRP on IGF-I. Indeed, a study reported inverse CRP–IGF-I correlations that were significant in only one of three ethnic groups [9].

Section snippets

Study sample

The CMHS was designed to compare 8-year longitudinal changes in serum hormone concentrations and growth factors between 624 black and 796 white male CARDIA subjects who had serum samples available at both year 2 (1987–88) and year 10 (1995–96) exams. Year 7 (1992–93) serum samples were not required to be available as part of the inclusion criteria, but were used in the CMHS, if available. A detailed description of the CMHS has been published elsewhere [33]. The present study examines

Results

Mean IGF-I (168 ng/ml in black and 186 ng/ml in white men) and IGFBP-3 (3076 ng/ml in black and 3445 ng/ml in white men) levels were significantly lower (p = 0.009 and p < 0.0001, respectively), and mean log CRP levels (−0.01 in black and −0.24 in white men) were significantly higher (p = 0.001) in black men compared to white men. Mean BMI, alcohol consumption, cigarettes smoked per day, and animal protein consumed generally increased across quartiles of CRP in both black and white men (Table 1). Mean

Discussion

Although the IGF-axis and inflammatory processes are important in several disease contexts, they generally have not been linked except in the setting of stunted growth in pediatric inflammatory and adult inflammatory conditions. In this study, we found an inverse association between CRP and IGF-I in black men but not white men. In black men, there was a 26 ng/ml difference in mean IGF-I levels between the highest and lowest quartiles of CRP. Smoking was a strong modifier of the effect of CRP on

Acknowledgements

This research was supported by U.S. Public Health Service grant RO1-CA770403 from the National Cancer Institute and U.S. Public Health Service contracts NO1-HC-48047, NO1-HC-48048, NO1-HC-48049, NO1-HC-48050, and NO1-HC-95095 from the National Heart, Lung, and Blood Institute. The authors had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

References (64)

  • G.R. Warnick et al.

    Enzymatic methods for quantification of lipoprotein lipids

    Methods Enzymol.

    (1986)
  • A.R. Dyer et al.

    Alcohol intake and blood pressure in young adults: the CARDIA Study

    J. Clin. Epidemiol.

    (1990)
  • A. McDonald et al.

    The CARDIA dietary history: development, implementation, and evaluation

    J. Am. Diet Assoc.

    (1991)
  • B.S. Kirschner et al.

    Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease

    Gastroenterology

    (1986)
  • K.H. Katsanos et al.

    Reduced serum insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 levels in adults with inflammatory bowel disease

    Growth Horm. IGF Res.

    (2001)
  • K. McGreevy et al.

    Racial and anthropometric differences in plasma levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3

    Urology

    (2005)
  • P. Cohen

    Overview of the IGF-I system

    Horm. Res.

    (2006)
  • F. De Benedetti et al.

    Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis

    Endocrinology

    (2001)
  • C. Gabay et al.

    Acute-phase proteins and other systemic responses to inflammation

    New Engl. J. Med.

    (1999)
  • F. De Benedetti et al.

    Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation

    J. Clin. Invest.

    (1997)
  • J.P. Thissen et al.

    Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor-I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture

    Endocrinology

    (1997)
  • J.T. Willerson et al.

    Inflammation as a cardiovascular risk factor

    Circulation

    (2004)
  • K. Kaushal et al.

    The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome

    Diabetes Care

    (2004)
  • L.H. Kuller et al.

    Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple risk factor intervention trial

    Am. J. Epidemiol.

    (1996)
  • P.M. Ridker et al.

    Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

    New Engl. J. Med.

    (1997)
  • G. Sesti et al.

    Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance

    Diabetes Care

    (2005)
  • K. Alexandraki et al.

    Inflammatory process in type 2 diabetes: the role of cytokines

    Ann. N.Y. Acad. Sci.

    (2006)
  • D. Il’yasova et al.

    Circulating levels of inflammatory markers and cancer risk in the health aging and body composition cohort

    Cancer Epidemiol. Biomar. Prev.

    (2005)
  • D. Trichopoulos et al.

    Plasma C-reactive protein and risk of cancer: a prospective study from Greece

    Cancer Epidemiol. Biomar. Prev.

    (2006)
  • J.M. Chan et al.

    Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study

    Science

    (1998)
  • J. Ma et al.

    Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3

    J. Natl. Cancer Inst.

    (1999)
  • H. Yu et al.

    Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis

    J. Natl. Cancer Inst.

    (1999)
  • Cited by (10)

    View all citing articles on Scopus
    1

    Request for reprints. Tel.: +1 312 908 0306; fax: +1 312 908 9588.

    View full text